Advertisement
β-blockers and angiotensin-converting enzyme inhibitors can prevent heart damage in breast cancer patients as they undergo chemotherapy

SABCS: β-Blockers, ACEIs May Protect Heart During Chemo

0
May also lower risk of complications that can interrupt breast cancer treatment
The expansion of insurance coverage and increases in retail prescription drug spending contributed to an increase in total national health care expenditures in 2014

U.S. Health Care Spending Increased in 2014

0
Increase in 2014 followed five consecutive years of historically low health care spending
Cardiometabolic outcomes and safety vary among different once-weekly glucagon-like peptide-1 receptor agonist treatments

Review Compares Outcomes, Safety for Once-Weekly GLP-1RAs

0
Greater reduction of HbA1c, fasting plasma glucose, body weight for dulaglutide, exenatide, taspoglutide
For patients with inflammatory bowel disease treated with anti-tumor necrosis factor therapy

Skin Lesions for 29 Percent With Anti-TNF Treatment in IBD

0
All but 11 percent of patients were managed successfully without needing to stop treatment
Oral venetoclax and acalabrutinib are active in patients with relapsed or refractory chronic lymphocytic leukemia

ASH: Venetoclax, Acalabrutinib Active in Relapsed CLL

0
Two studies show beneficial effects for patients with relapsed chronic lymphocytic leukemia
The rate of vaso-occlusive crisis events is not significantly lower for children and adolescents with sickle-cell anemia receiving prasugrel versus placebo

ASH: Prasugrel Doesn’t Cut Vaso-Occlusive Crisis in Sickle Cell

0
Rate of vaso-occlusive crisis events is not lower for children receiving prasugrel versus placebo
Androgen deprivation therapy for prostate cancer might dramatically increase a man's risk of developing Alzheimer's disease

ADT for Prostate CA Tied to Increased Alzheimer’s Risk

0
Research suggests dose-dependent effect
Cannabidiol might benefit some children with epilepsy whose seizures aren't controlled by approved medications

Cannabidiol Shows Promise in Pediatric Epilepsy

0
Preliminary studies link cannabidiol to seizure reduction, but drug interactions remain a concern
Fewer American families are struggling to pay medical bills

CDC: Fewer Americans Struggling With Medical Bills

0
U.S. report shows 12 million are no longer in families having trouble paying for health care
Kanuma (sebelipase alfa) has been approved by the U.S. Food and Drug Administration as the first treatment for LAL deficiency (Wolman disease or cholesteryl ester storage disease).

FDA Approves Kanuma for Lysosomal Acid Lipase Deficiency

0
For treatment of LAL deficiency, also known as Wolman disease or cholesteryl ester storage disease